Eulalia Olesti
Overview
Explore the profile of Eulalia Olesti including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
308
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Murias-Closas A, Prats C, Calvo G, Lopez-Codina D, Olesti E
EBioMedicine
. 2025 Mar;
113:105597.
PMID: 40023046
Chimeric Antigen Receptor (CAR) T-cell therapy is characterised by the heterogeneous cellular kinetic profile seen across patients. Unlike traditional chemotherapy, which displays predictable dose-exposure relationships resulting from well-understood pharmacokinetic processes,...
2.
Zugasti I, Tormo-Ratera M, Oliver-Caldes A, Soler-Perromat J, Gonzalez-Calle V, Moreno D, et al.
Blood Adv
. 2024 Nov;
9(3):571-582.
PMID: 39602341
Multiple myeloma (MM) remains incurable, with poor outcomes in heavily pretreated patients. Chimeric antigen receptor (CAR) T-cell therapy has emerged as a promising treatment; however, outcomes after such therapy in...
3.
Bachiller M, Barcelo-Genestar N, Rodriguez-Garcia A, Alserawan L, Dobano-Lopez C, Gimenez-Alejandre M, et al.
Mol Ther
. 2024 Nov;
33(1):317-335.
PMID: 39563035
CD19 CAR-T therapy has achieved remarkable responses in relapsed/refractory non-Hodgkin lymphoma (NHL). However, challenges persist, with refractory responses or relapses after CAR-T administration linked to CD19 loss or downregulation. Given...
4.
Oliver-Caldes A, Espanol-Rego M, Zabaleta A, Gonzalez-Calle V, Navarro-Velazquez S, Inoges S, et al.
Clin Cancer Res
. 2024 Mar;
30(10):2085-2096.
PMID: 38466644
Purpose: B-cell maturation antigen (BCMA)-chimeric antigen receptor T-cells (CART) improve results obtained with conventional therapy in the treatment of relapsed/refractory multiple myeloma. However, the high demand and expensive costs associated...
5.
Olesti E, Nuevo Y, Bachiller M, Guillen E, Bascuas J, Varea S, et al.
Cytotherapy
. 2024 Jan;
26(3):221-230.
PMID: 38260921
Advanced therapy medicinal products (ATMPs) are becoming the new kid on the block for the treatment of a variety of indications with promising results. Despite the academic contribution to the...
6.
Poinot H, Dupuychaffray E, Arnoux G, Alvarez M, Tachet J, Ezzar O, et al.
Oncoimmunology
. 2024 Jan;
13(1):2286820.
PMID: 38170044
Although immune-based therapies have revolutionized the management of cancer, novel approaches are urgently needed to improve their outcome. We investigated the role of endogenous steroids in the resistance to cancer...
7.
Present and future of metabolic and metabolomics studies focused on classical psychedelics in humans
Madrid-Gambin F, Fabregat-Safont D, Gomez-Gomez A, Olesti E, Mason N, Ramaekers J, et al.
Biomed Pharmacother
. 2023 Nov;
169:115775.
PMID: 37944438
Psychedelics are classical hallucinogen drugs that induce a marked altered state of consciousness. In recent years, there has been renewed attention to the possible use of classical psychedelics for the...
8.
Martinez-Cibrian N, Ortiz-Maldonado V, Espanol-Rego M, Blazquez A, Cid J, Lozano M, et al.
Br J Haematol
. 2023 Oct;
204(2):525-533.
PMID: 37905734
Varnimcabtagene autoleucel (var-cel) is an academic anti-CD19 chimeric antigen receptor (CAR) product used for the treatment of non-Hodgkin lymphoma (NHL) in the CART19-BE-01 trial. Here we report updated outcomes of...
9.
Oliver-Caldes A, Gonzalez-Calle V, Cabanas V, Espanol-Rego M, Rodriguez-Otero P, Reguera J, et al.
Lancet Oncol
. 2023 Jul;
24(8):913-924.
PMID: 37414060
Background: Chimeric antigen receptor (CAR) T-cell therapy is a promising option for patients with heavily treated multiple myeloma. Point-of-care manufacturing can increase the availability of these treatments worldwide. We aimed...
10.
Olesti E, Boccard J, Rahban R, Girel S, Moskaleva N, Zufferey F, et al.
Metabolomics
. 2023 Jun;
19(6):53.
PMID: 37271779
Introduction: A decrease in sperm cell count has been observed along the last several decades, especially in the most developed regions of the world. The use of metabolomics to study...